Antibodies and Vaccines as Drugs for COVID-19

9 Things You Need To Know About Molnupiravir, a New COVID-19 Pill > News > Yale Medicine

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials

Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023

Why you shouldn't get a COVID antibody test after a vaccine

COVID-19 vaccine elicits antibodies in 90% taking immunosuppressants – Washington University School of Medicine in St. Louis

Development of vaccines and antivirals for combating viral pandemics

In search of COVID-19 antibodies

Experts say monoclonal antibody treatment is not a substitute for COVID-19 vaccines

Why experts say monoclonal antibodies aren't vaccine substitute - ABC News

Two new drugs could fight COVID-19 – The Hill

Commercialization of COVID-19 Vaccines, Treatments, and Tests: Implications for Access and Coverage

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies｜Institute of Cellular and Organismic Biology, Academia Sinica